Label: URINARY PAIN RELIEF- phenazopyridine hydrochloride tablet

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: unapproved drug other

DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

Drug Label Information

Updated August 1, 2022

If you are a consumer or patient please visit this version.

  • ACTIVE INGREDIENT

    Active ingredient (in each tablet)

    Phenazopyridine Hydrochloride 99.5 mg

  • PURPOSE

    Purpose

    Urinary Tract Analgesic

  • KEEP OUT OF REACH OF CHILDREN

    Keep out of reach of children. In case of an overdose, get medical help or contact poison Control Center right away.

  • INDICATIONS & USAGE

    Use Relief from urinary pain, burning, urgency and frequency associated with urinary tract infections.

  • WARNINGS

    Please read insert for important precautions.

    Ask a doctor before use if you have:

    ■ kidney disease

    ■ allergies to foods, preservatives or dyes

    ■ had a hypersensitive reaction to Phenazopyridine Hydrochloride

    Do not use if you have Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency unless approved by your physician.

    When using this product

    ■ stomach upset may occur, taking this product with or after meals may reduce stomach upset

    ■ your urine will become reddish-orange in color. This is not harmful, but care should be taken to avoid staining clothing or other items.

    Stop use and ask a doctor if

    ■ your symptoms last for more than 2 days

    ■ you suspect you are having an adverse reaction to the medication

    ■ Long-term adminitration of phenazopyridine hydrochloride has induced neoplasia in rats (large instestine) andmice (liver). Although no association between phenazopyridine hydrochloride and human enoplasia has beeen reported, adequate epidemiological studies along these lines have not been conducted.

    If pregnant or breast-feeding, ask a health professional before use. A pregnancy test and consultation with a health professional if pregnancy is confirmed is recommended prior to use.

    Keep out of reach of children. In case of an overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

  • OTHER SAFETY INFORMATION

    ■ This product can interfere with laboratory tests including urine, glucose (sugar), and ketones tests

    ■ This product may stain contact lenses and other items if handled after touching tablets

    ■ long term administration of phenazopyridine HCI has induced neoplasia in rats (large intestine) and mice (liver). Although no association between phenazopyridine hydrochloride and human neoplasia has been reported, adequate epidemiological studies along these lines have not been conducted

    ■ Store at room temperature 15°-30°C (59°-86°F) in a dry place and protect from light

  • DOSAGE & ADMINISTRATION

    Adults and children 12 years of age and over: Take 2 tablets 3 times daily with or after meals as needed for up to two days. Take with a full glass of water. Do not use for more than 2 days (12 tablets) without consulting a doctor

    ■ Children under 12: Do not use wihout consulting a doctor

  • INACTIVE INGREDIENT

    pregelatinized starch, microcrystalline cellulose, maize (corn) starch, povidone, croscarmellose sodium, magnesium stearate, colloidal silicon dioxide, hydroxypropyl methylcellulose, polyethylene glycol

  • QUESTIONS

    call toll-free 1-845-547-2667

  • SPL UNCLASSIFIED SECTION

    Size and color of tablets may vary.

    *This product is not manufactured or distributed by the owner of the registered trademark AZO Urinary Pain Relief®.

    Distributed by: Safrel Pharmaceuticals, LLC

    Bridgewater, NJ 08807

  • PRINCIPAL DISPLAY PANEL

    Compare to the active ingredient in AZO Urinary Pain Relief® Maximum Strength*

    MAXIMUM STRENGTH

    Urinary Pain Relief

    PHENAZOPYRIDINE HYDROCHLORIDE 99.5 mg

    Quickly eases urinary pain, burning & urgency

    • More active ingredient for maximum relief

    • Provides targeted relief for urinary pain

    NDC 71309-779-72 - 72 Count

    72 Count

    NDC 71309-779-28- 28Count

    28 Count

  • INGREDIENTS AND APPEARANCE
    URINARY PAIN RELIEF 
    phenazopyridine hydrochloride tablet
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:71309-779
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    PHENAZOPYRIDINE HYDROCHLORIDE (UNII: 0EWG668W17) (PHENAZOPYRIDINE - UNII:K2J09EMJ52) PHENAZOPYRIDINE HYDROCHLORIDE99.5 mg
    Inactive Ingredients
    Ingredient NameStrength
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO)  
    STARCH, CORN (UNII: O8232NY3SJ)  
    POLYETHYLENE GLYCOL 400 (UNII: B697894SGQ)  
    CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  
    POVIDONE K30 (UNII: U725QWY32X)  
    CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
    Product Characteristics
    ColorbrownScoreno score
    ShapeROUNDSize7mm
    FlavorImprint Code
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:71309-779-7272 in 1 BOTTLE; Type 0: Not a Combination Product08/01/2022
    2NDC:71309-779-2828 in 1 BOTTLE; Type 0: Not a Combination Product08/01/2022
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    unapproved drug other08/01/2022
    Labeler - Safrel Pharmaceuticals, LLC. (080566287)